InvestorsHub Logo

randychub

07/24/20 10:26 AM

#233832 RE: DewDiligence #233825

ABUS - Any thoughts on value of ABUS if this patent dispute holds up. If Moderna’s vaccine gets anywhere near the
$10 billion to $20 billion annual revenue estimate recently provided by Jefferies analyst Michael Yee and ABUS gets 2%.

Thanks Randy